Evidence map›Paper›PMID 40128234›Full record

ArticleScientific reports2025

Cholesterol depletion suppresses thermal necrosis resistance by alleviating an increase in membrane fluidity.

Taisei Kanamori, Shogo Yasuda, Runjing Duan, Mei Ohashi, Mai Amou, Kanato Hori, Ryota Tsuda, Taiki Fujimoto, Kenjirou Higashi, Wei Xu and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Adaptation to heat stress by diversification of the vertebrate heat shock transcription factor family.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Taisei KanamoriLaboratory of Clinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, 260-0856, Japan.
Shogo YasudaLaboratory of Clinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, 260-0856, Japan.
Runjing DuanLaboratory of Clinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, 260-0856, Japan.
Mei OhashiLaboratory of Clinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, 260-0856, Japan.
Mai AmouLaboratory of Clinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, 260-0856, Japan.
Kanato HoriLaboratory of Clinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, 260-0856, Japan.
Ryota TsudaLaboratory of Clinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, 260-0856, Japan.
Taiki FujimotoLaboratory of Pharmaceutical Technology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, 260-0856, Japan.
Kenjirou HigashiLaboratory of Pharmaceutical Technology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, 260-0856, Japan.
Wei XuFaculty of Advanced Science and Technology, Graduate School of Science and Technology, Kumamoto University, Kumamoto, 860-8555, Japan.
Takuro NiidomeFaculty of Advanced Science and Technology, Graduate School of Science and Technology, Kumamoto University, Kumamoto, 860-8555, Japan.
Hiroto HatakeyamaLaboratory of Clinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, 260-0856, Japan. h-hatakeyama@chiba-u.jp.

Funding

Japan Society and Technology Agency JPMJSP2109Japan Society for the Promotion of Science 18H04686Japan Society for the Promotion of Science 23KJ0301
6 · The paper itself

Abstract

Thermally resistant cancer cells suppress the therapeutic effects of hyperthermia. However, the mechanism underlying the thermal resistance remains unclear. With the aim of enhancing the therapeutic effects of hyperthermia, we investigated the mechanism underlying thermal resistance. We found that heat shock-induced cell death can be classified into two types: late-phase apoptosis and early-phase necrosis. Cell death was suppressed in thermally resistant cells. In addition, heat-induced necrosis resistance correlated with plasma membrane fluidity, which was maintained by cholesterol. Depletion of cholesterol from cancer cells and tumor tissues enhanced the effect of hyperthermia under both in vivo and in vitro conditions. Hence, the findings demonstrate the usefulness of cholesterol as a marker for thermally resistant cancer cells. Furthermore, the combination of cholesterol depletion and hyperthermia may be a new therapeutic strategy for thermally resistant cancers.

Indexed as

CholesterolMembrane FluidityNecrosisAnimalsApoptosisCell Line, TumorCell MembraneHeat-Shock ResponseHumansHyperthermia, InducedMiceNeoplasmsCholesterol

Identifiers

PMID40128234
PMCPMC11933367

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.